AEMD

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Aethlon Medical Inc

NASDAQ | AEMD

4.26

USD

$0.00

(

0.00%

)

At Close (As of Nov 6, 2025)

$3.43M

Market Cap

-

P/E Ratio

-66.7

EPS

$84.40

52 Week High

$4.23

52 Week Low

HEALTHCARE

Sector

AEMD Chart

Recent Chart
Price Action

AEMD Technicals

Tags:

AEMD Earnings

Yearly Income Statement (As of Mar 31, 2025)

Field Value (USD)
Gross Profit -$340K
Total Revenue $0
Cost Of Revenue $340K
Costof Goods And Services Sold $340K
Operating Income -$9.3M
Selling General And Administrative $3.2M
Research And Development $2.2M
Operating Expenses $9.3M
Investment Income Net -
Net Interest Income $288K
Interest Income $298K
Interest Expense $10K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $340K
Income Before Tax -$13M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$13M
Comprehensive Income Net Of Tax -
Ebit -$13M
Ebitda -$13M
Net Income -$13M

Revenue & Profitability

Earnings Performance

AEMD Financials

yearly Balance Sheet (As of Mar 31, 2025)

Field Value (USD)
Total Assets $7.4M
Total Current Assets $5.9M
Cash And Cash Equivalents At Carrying Value $5.5M
Cash And Short Term Investments $5.5M
Inventory -
Current Net Receivables -
Total Non Current Assets $1.4M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $550
Intangible Assets Excluding Goodwill $550
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $449K
Other Non Current Assets -
Total Liabilities $2.2M
Total Current Liabilities $1.9M
Current Accounts Payable $535K
Deferred Revenue -
Current Debt -
Short Term Debt $313K
Total Non Current Liabilities $337K
Capital Lease Obligations $650K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $650K
Other Current Liabilities $1.1M
Other Non Current Liabilities -
Total Shareholder Equity $5.1M
Treasury Stock -
Retained Earnings -$168M
Common Stock $2.6K
Common Stock Shares Outstanding $156K

yearly Cash Flow (As of Mar 31, 2025)

Field Value (USD)
Operating Cashflow -$7.6M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $340K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $7.7M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$13M

yearly Income Statement (As of Mar 31, 2025)

Field Value (USD)
Gross Profit -$340K
Total Revenue $0
Cost Of Revenue $340K
Costof Goods And Services Sold $340K
Operating Income -$9.3M
Selling General And Administrative $3.2M
Research And Development $2.2M
Operating Expenses $9.3M
Investment Income Net -
Net Interest Income $288K
Interest Income $298K
Interest Expense $10K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $340K
Income Before Tax -$13M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$13M
Comprehensive Income Net Of Tax -
Ebit -$13M
Ebitda -$13M
Net Income -$13M

AEMD News

AEMD Profile

Aethlon Medical Inc Profile

Sector: HEALTHCARE

Industry: MEDICAL DEVICES

Aethlon Medical, Inc. (AEMD) is an innovative medical technology company headquartered in San Diego, California, dedicated to developing cutting-edge products for the diagnosis and treatment of critical and organ-threatening diseases. With a robust proprietary platform, Aethlon focuses on addressing significant unmet medical needs, thereby improving patient outcomes. The company's strong commitment to research and development solidifies its position as a key player in the medical technology sector, actively advancing therapeutic solutions that cater to the evolving healthcare landscape.

WORX
+33.21%
$0.38
YGMZ
+44.57%
$0.18
BIYA
+73.32%
$0.47
NVDA
-3.65%
$188.08
ASST
-0.68%
$1.45
EZGO
+37.90%
$0.20
BYND
-6.29%
$1.19
CHR
-14.86%
$0.06
SNAP
+9.72%
$8.01
MTC
+25.33%
$2.77
PFE
+0.97%
$24.85
TSLA
-3.49%
$445.91
AZI
+12.92%
$0.09
VHAI
0.00%
$0.00
RIVN
-1.29%
$15.22
PLUG
-4.92%
$2.50
SOFI
-9.67%
$27.16
DNN
-4.11%
$2.56
IOVA
+27.62%
$2.31
F
+0.07%
$13.12
ONDS
-12.50%
$5.25
PLTR
-6.83%
$175.05
WTO
-6.25%
$0.04
YDKG
0.00%
$0.05
INTC
-2.97%
$37.24
STGW
+16.83%
$5.62
T
+0.73%
$24.74
NIO
-1.78%
$7.16
BITF
-9.11%
$3.69
AXDX
-61.36%
$0.03
AAL
-2.01%
$13.15
AMD
-7.26%
$237.70
FTEL
-31.98%
$1.51
KVUE
+1.41%
$16.46
ACHR
-7.21%
$8.88
BURU
-6.81%
$0.27
BAC
+1.60%
$53.29
CIFR
-12.14%
$21.71
GRAB
-0.17%
$5.63
AAPL
-0.13%
$269.77
ADAP
-15.14%
$0.05
LYFT
+5.82%
$21.25
BTG
-5.70%
$3.80
HOOD
-10.80%
$127.08
IREN
-12.36%
$66.95
WBD
-1.49%
$22.42
IONZ
-7.99%
$3.80
ETHD
+8.25%
$4.84
RGTI
-7.85%
$34.36
AMZN
-2.86%
$243.04
NUAI
+6.52%
$6.04
NEHC
+6.52%
$6.04
NVO
-4.02%
$46.51
HIMS
-5.05%
$41.52
EPWK
+1.42%
$0.07
BTBT
-7.62%
$3.03
AMCR
+1.85%
$8.22
SOUN
-9.47%
$14.23
QBTS
-8.47%
$28.39
XPEV
+9.63%
$23.89
GPUS
-4.97%
$0.37
RMBL
+60.50%
$3.21
DVLT
-15.00%
$1.36
JOBY
-4.53%
$14.32
CELH
-24.79%
$45.06
MARA
-6.83%
$15.96
BMNR
-9.77%
$37.36
ADD
-25.47%
$0.05
RIG
0.00%
$3.90
RXRX
-6.85%
$4.62
CAN
-12.40%
$1.12
HL
+11.89%
$13.55
TLRY
-5.46%
$1.21
EOSE
+2.89%
$15.29
GOOGL
+0.15%
$284.75
IONQ
+3.64%
$57.43
SRM
+53.27%
$10.30
NOK
+0.87%
$6.91
DKNG
+0.21%
$27.98
WULF
-7.03%
$14.28
VALE
-0.64%
$12.23
RUBI
-26.47%
$0.22
BBD
-0.56%
$3.51
PINS
+2.05%
$26.28
SMCI
-4.03%
$40.33
PLTZ
+13.94%
$7.11
CMG
-4.41%
$30.56
MU
+0.34%
$238.33
ACVA
-37.54%
$5.09
VZ
+0.32%
$39.82
OSCR
-2.75%
$16.55
PLTD
+6.98%
$6.89
CCCS
-2.80%
$7.62
CCC
-2.80%
$7.62
NGD
+1.76%
$6.92
KHC
-1.73%
$23.72
KMX
-24.33%
$30.88
ABEV
-0.82%
$2.40
WLGS
-5.57%
$0.04
MRVL
+0.46%
$93.33
WORX
+33.21%
$0.38
YGMZ
+44.57%
$0.18
BIYA
+73.32%
$0.47
NVDA
-3.65%
$188.08
ASST
-0.68%
$1.45
EZGO
+37.90%
$0.20
BYND
-6.29%
$1.19
CHR
-14.86%
$0.06
SNAP
+9.72%
$8.01
MTC
+25.33%
$2.77
PFE
+0.97%
$24.85
TSLA
-3.49%
$445.91
AZI
+12.92%
$0.09
VHAI
0.00%
$0.00
RIVN
-1.29%
$15.22
PLUG
-4.92%
$2.50
SOFI
-9.67%
$27.16
DNN
-4.11%
$2.56
IOVA
+27.62%
$2.31
F
+0.07%
$13.12
ONDS
-12.50%
$5.25
PLTR
-6.83%
$175.05
WTO
-6.25%
$0.04
YDKG
0.00%
$0.05
INTC
-2.97%
$37.24
STGW
+16.83%
$5.62
T
+0.73%
$24.74
NIO
-1.78%
$7.16
BITF
-9.11%
$3.69
AXDX
-61.36%
$0.03
AAL
-2.01%
$13.15
AMD
-7.26%
$237.70
FTEL
-31.98%
$1.51
KVUE
+1.41%
$16.46
ACHR
-7.21%
$8.88
BURU
-6.81%
$0.27
BAC
+1.60%
$53.29
CIFR
-12.14%
$21.71
GRAB
-0.17%
$5.63
AAPL
-0.13%
$269.77
ADAP
-15.14%
$0.05
LYFT
+5.82%
$21.25
BTG
-5.70%
$3.80
HOOD
-10.80%
$127.08
IREN
-12.36%
$66.95
WBD
-1.49%
$22.42
IONZ
-7.99%
$3.80
ETHD
+8.25%
$4.84
RGTI
-7.85%
$34.36
AMZN
-2.86%
$243.04
NUAI
+6.52%
$6.04
NEHC
+6.52%
$6.04
NVO
-4.02%
$46.51
HIMS
-5.05%
$41.52
EPWK
+1.42%
$0.07
BTBT
-7.62%
$3.03
AMCR
+1.85%
$8.22
SOUN
-9.47%
$14.23
QBTS
-8.47%
$28.39
XPEV
+9.63%
$23.89
GPUS
-4.97%
$0.37
RMBL
+60.50%
$3.21
DVLT
-15.00%
$1.36
JOBY
-4.53%
$14.32
CELH
-24.79%
$45.06
MARA
-6.83%
$15.96
BMNR
-9.77%
$37.36
ADD
-25.47%
$0.05
RIG
0.00%
$3.90
RXRX
-6.85%
$4.62
CAN
-12.40%
$1.12
HL
+11.89%
$13.55
TLRY
-5.46%
$1.21
EOSE
+2.89%
$15.29
GOOGL
+0.15%
$284.75
IONQ
+3.64%
$57.43
SRM
+53.27%
$10.30
NOK
+0.87%
$6.91
DKNG
+0.21%
$27.98
WULF
-7.03%
$14.28
VALE
-0.64%
$12.23
RUBI
-26.47%
$0.22
BBD
-0.56%
$3.51
PINS
+2.05%
$26.28
SMCI
-4.03%
$40.33
PLTZ
+13.94%
$7.11
CMG
-4.41%
$30.56
MU
+0.34%
$238.33
ACVA
-37.54%
$5.09
VZ
+0.32%
$39.82
OSCR
-2.75%
$16.55
PLTD
+6.98%
$6.89
CCCS
-2.80%
$7.62
CCC
-2.80%
$7.62
NGD
+1.76%
$6.92
KHC
-1.73%
$23.72
KMX
-24.33%
$30.88
ABEV
-0.82%
$2.40
WLGS
-5.57%
$0.04
MRVL
+0.46%
$93.33
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.